Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase III study of Trikafta in cystic fibrosis meets primary and secondary endpoints

July 21, 2020

Three COVID-19 vaccines generate T-cell responses

July 21, 2020

Hillstream Biopharma presents preclinical data for HSB-1216 in cancer

July 21, 2020

SERENITY I and SERENITY II pivotal studies meet primary and secondary endpoints

July 21, 2020

First-in-human study of anticoagulant ONO-7684 successful in healthy subjects

July 21, 2020

Positive interim efficacy and safety data presented for BNZ-1

July 21, 2020

First patient dosed in pivotal phase II portion of LOTIS 3 study

July 21, 2020

Daiichi Sankyo describes new RXR agonists

July 21, 2020

RaQualia Pharma presents new SCN9A and SCN10A channel blockers

July 21, 2020

GlycoMimetics synthesizes new LGALS3 inhibitors

July 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...